Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

Trial Profile

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase of Trial: Phase II

Latest Information Update: 08 Feb 2019

At a glance

  • Drugs Avelumab (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Acronyms SEJ
  • Most Recent Events

    • 23 Oct 2018 Trial design presented at the 43rd European Society for Medical Oncology Congress
    • 31 Aug 2018 Biomarkers information updated
    • 13 Mar 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top